Ligand validation:3N64

XFN: 6,6'-[(5-aminobenzene-1,3-diyl)diethane-2,1-diyl]bis(4-methylpyridin-2-amine)

XFN is a Ligand Of Interest in 3N64 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3N64_XFN_B_800	50%	33%	0.185	0.938	0.76	1.99	-	12	1	0	100%	1
3N64_XFN_A_800	26%	27%	0.268	0.913	0.81	2.27	1	12	0	0	100%	1
3N66_XFN_B_800	52%	27%	0.161	0.918	0.88	2.21	1	12	1	0	100%	1
3N60_XFN_B_800	35%	28%	0.227	0.915	0.95	2.08	-	10	1	0	100%	1
3N63_XFN_B_800	34%	25%	0.209	0.891	1.04	2.15	2	13	1	0	100%	1
4D3J_XFN_A_904	52%	18%	0.14	0.898	1.57	2.14	6	11	1	0	100%	1
3N5Q_XFN_B_800	27%	43%	0.264	0.91	0.56	1.68	-	8	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.